Nestlé Health Science Archives

News and Trends 18 Jul 2022

Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease

Enterome, a clinical stage biopharmaceutical company developing immunomodulatory drugs based on its bacterial Mimicry drug discovery platform, has signed a strategic R&D collaboration and license agreement with Nestlé Health Science targeting food allergies and inflammatory bowel disease (IBD). The collaboration aims to develop and commercialize Enterome’s lead EndoMimics pipeline candidate EB1010. EB1010 is a local […]

July 18, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 6 Feb 2020

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

In a deal worth up to €67M, industry giant Nestlé Health Science will have the global rights to commercialize Valbiotis’ food supplement for lowering the rate of type 2 diabetes in people at high risk of developing the condition. Under the terms of the deal, the French biotech will receive an upfront payment of €4.7M […]

February 6, 2020 - 2 minutesmins - By Jonathan Smith

artificial intelligence peptides nuritas 1

News and Trends 14 Feb 2018

Nestlé and AI Biotech Hunt Down Bioactive Peptides in Our Food

Nuritas and Nestlé will use artificial intelligence to find bioactive peptides in the food we eat for applications including diabetes, anti-aging, and animal and plant health. Nuritas wants to revolutionize the discovery of natural active ingredients that can support and improve human health. The company uses artificial intelligence (AI) to look closely at the foods we […]

February 14, 2018 - 3 minutesmins - By Alex Dale

Microbiome Diagnostics Partners Enterome Nestle e1517266503234

News and Trends 11 Jul 2017

Enterome and Nestle Launch a New Microbiome Diagnostics Company

Microbiome Diagnostics Partners will develop diagnostics tests with Enterome’s microbiome platform IP and a €20M investment from Nestlé. Nestlé Health Science and Enterome have created Microbiome Diagnostics Partners (MDP) as a joint venture split 50% between both parties. Nestlé has invested €20M for its stake in the new company as well as the exclusive option to commercialize […]

July 11, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 31 May 2016

DBV Technologies: “This is our First and most Significant Partnership signed”

The billion-euro Biotech from Paris DBV Technologies just signed a €100M deal with Nestlé Health Science to develop a new diagnostic test of Milk allergies. This is the first deal of DBV and shows the potential of its technological platform. I had a chat with its COO David Schilansky to find out more… DBV is […]

May 31, 2016 - 4 minutesmins - By Philip Hemme

clostridium difficile microbiomics seres health therapeutics nestle science crohns ibd uc cdi

News and Trends 12 Jan 2016

Microbiomics and Nestlé: €1.7Bn for New TransAtlantic Drug Development Program

Microbiomics is a hot area for biotech. Now US Seres Therapeutics and Nestlé Health Sciences have signed a massive drug development deal for bowel diseases and C.difficile infections. By correcting the fundamental microbiome dysbiosis that is the root cause of many diseases, Seres Theraputics in Cambridge (US) is creating a profoundly new and important way […]

January 12, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 28 Sep 2015

New Smart Collaboration of Nestlé and AC Immune Against Alzheimer’s disease

Nestlé Institute of Health Sciences (NIHS) is teaming up with the Swiss AC Immune to develop a new minimally invasive Tau diagnostic assay for early diagnosis of Alzheimer’s disease. Alzheimer’s disease has a new case every three seconds, totaling up to 9.9 million new cases of dementia every year. To combat this, AC Immune will […]

September 28, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 9 Jan 2015

Will Nestlé lead the promising microbiome industry?

Nestlé is one of the food giants in the World. Last Tuesday, it made a huge step in the microbiome industry by investing $65M in Boston-based Seres Health, one of the most advanced Biotech start-ups in the field. Will Nestlé take control of the promising microbiome industry? Seres Health is a leading microbiome therapeutics platform company developing […]

January 9, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Nestlé Health Science

Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

Nestlé and AI Biotech Hunt Down Bioactive Peptides in Our Food

Enterome and Nestle Launch a New Microbiome Diagnostics Company

DBV Technologies: “This is our First and most Significant Partnership signed”

Microbiomics and Nestlé: €1.7Bn for New TransAtlantic Drug Development Program

New Smart Collaboration of Nestlé and AC Immune Against Alzheimer’s disease

Will Nestlé lead the promising microbiome industry?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!